Case Name: Horizon Medicines LLC v. Apotex Inc., Civ. No. 22-640-CJB, 2022 WL 16739909 (D. Del. Nov. 7, 2022) (Burke, M.J.) Drug Product and Patent(s)-in-Suit: Pennsaid® 2% (diclofenac.
Nuvo Pharmaceuticals (OTCMKTS:MRVFF – Get Rating) and Petros Pharmaceuticals (NASDAQ:PTPI – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, earnings, analyst recommendations and profitability. Profitability This table compares Nuvo Pharmaceuticals and Petros Pharmaceuticals’ […]
Nuvo Pharmaceuticals (OTCMKTS:MRVFF – Get Rating) is one of 939 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare Nuvo Pharmaceuticals to related companies based on the strength of its earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations. Earnings & Valuation This […]
/PRNewswire/ The "Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com s offering..